Spinocerebellar ataxia type 40

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:423275OMIM:616053G11.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Spinocerebellar ataxia type 40 (SCA40) is a rare inherited brain condition that affects movement and coordination. It belongs to a group of diseases called spinocerebellar ataxias, which cause damage to the cerebellum — the part of the brain that controls balance and smooth movement — as well as the spinal cord pathways connected to it. In SCA40, the main problem is that the cerebellum gradually stops working as well as it should. This leads to unsteady walking, poor coordination, and trouble with fine movements like writing or buttoning a shirt. Some people also develop problems with speech, making it sound slurred or slow. The condition tends to get worse over time, though the speed of progression can vary from person to person. There is currently no cure for SCA40. Treatment focuses on managing symptoms and maintaining quality of life for as long as possible. Physical therapy, occupational therapy, and speech therapy are the main tools used to help people stay as independent as possible. Researchers are actively studying the disease to find better treatments in the future.

Also known as:

Key symptoms:

Unsteady walking and balance problems (ataxia)Poor coordination of arms and handsSlurred or slow speechDifficulty with fine motor tasks like writing or using utensilsTremor or shakiness with movementAbnormal eye movementsMuscle stiffness or spasticityFatigue with physical activityDifficulty swallowing in some cases

Clinical phenotype terms (14)— hover any for plain English
Vertical supranuclear gaze palsyHP:0000511Scanning speechHP:0002168Pontocerebellar atrophyHP:0006879
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Spinocerebellar ataxia type 40.

View clinical trials →

No actively recruiting trials found for Spinocerebellar ataxia type 40 at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Spinocerebellar ataxia type 40 community →

No specialists are currently listed for Spinocerebellar ataxia type 40.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Spinocerebellar ataxia type 40.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Spinocerebellar ataxia type 40Forum →

No community posts yet. Be the first to share your experience with Spinocerebellar ataxia type 40.

Start the conversation →

Latest news about Spinocerebellar ataxia type 40

No recent news articles for Spinocerebellar ataxia type 40.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What stage is my condition at, and what changes should I expect over the next few years?,Should I have genetic testing, and should my family members be tested too?,What therapies do you recommend to help me stay mobile and independent for as long as possible?,Are there any clinical trials for SCA40 or related spinocerebellar ataxias that I might qualify for?,When should I start thinking about mobility aids or home modifications?,Are there any medications that might help with my specific symptoms like stiffness or tremor?,What specialists should be part of my care team, and how often should I be seen?

Common questions about Spinocerebellar ataxia type 40

What is Spinocerebellar ataxia type 40?

Spinocerebellar ataxia type 40 (SCA40) is a rare inherited brain condition that affects movement and coordination. It belongs to a group of diseases called spinocerebellar ataxias, which cause damage to the cerebellum — the part of the brain that controls balance and smooth movement — as well as the spinal cord pathways connected to it. In SCA40, the main problem is that the cerebellum gradually stops working as well as it should. This leads to unsteady walking, poor coordination, and trouble with fine movements like writing or buttoning a shirt. Some people also develop problems with speech,

How is Spinocerebellar ataxia type 40 inherited?

Spinocerebellar ataxia type 40 follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Spinocerebellar ataxia type 40 typically begin?

Typical onset of Spinocerebellar ataxia type 40 is adult. Age of onset can vary across affected individuals.